The biologization of industry is more or less correct, but we're not going to get antibody boxes (using current technology - yes there are some ideas kicking ar

The biologization of industry is more or less correct, but we're not going to get antibody boxes (using current technology - yes there are some ideas kicking around and I'm thinking of someday doing a startup on it but initial capital expenses are high for industrial biotech and largely incompatible IMO with sv style vc); antibodies are not solely defined by their DNA sequencing and correctly manufacturing them is not simple.